Patents by Inventor Ewa M. Davison

Ewa M. Davison has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tumor suppressor pathway in
    Patent number: 7670778
    Abstract: The invention provides novel lin-8, lin-56, and lin-61 genes and polypeptides involved in cell fate determination and in cell proliferation. In addition, the invention includes mutants of these three genes, as well as methods for utilizing these genes, and their encoded polypeptides, in diagnosing and treating abnormal cell proliferation.
    Type: Grant
    Filed: October 4, 2007
    Date of Patent: March 2, 2010
    Assignee: Massachusetts Institute of Technolgoy
    Inventors: H. Robert Horvitz, Ewa M. Davison, Xiaowei Lu
  • Tumor suppressor pathway in C. elegans
    Publication number: 20080213777
    Abstract: The invention provides novel lin-8, lin-56, and lin-61 genes and polypeptides involved in cell fate determination and in cell proliferation. In addition, the invention includes mutants of these three genes, as well as methods for utilizing these genes, and their encoded polypeptides, in diagnosing and treating abnormal cell proliferation.
    Type: Application
    Filed: October 4, 2007
    Publication date: September 4, 2008
    Inventors: H. Robert Horvitz, Ewa M. Davison, Xiaowei Lu
  • Tumor suppressor pathway in C. elegans
    Publication number: 20040229267
    Abstract: The invention provides novel lin-61 genes and polypeptides involved in cell fate determination and in cell proliferation, as well as methods for utilizing these genes, and their encoded polypeptides, in identifying compounds that modulate cell proliferation.
    Type: Application
    Filed: May 6, 2004
    Publication date: November 18, 2004
    Inventors: H. Robert Horvitz, Ewa M. Davison, Xiaowei Lu
  • Tumor suppressor pathway in C. elegans
    Publication number: 20020137906
    Abstract: The invention provides novel lin-8, lin-56, and lin-61 genes and polypeptides involved in cell fate determination and in cell proliferation. In addition, the invention includes mutants of these three genes, as well as methods for utilizing these genes, and their encoded polypeptides, in diagnosing and treating abnormal cell proliferation.
    Type: Application
    Filed: June 1, 2001
    Publication date: September 26, 2002
    Inventors: H. Robert Horvitz, Ewa M. Davison, Xiaowei Lu